Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 1 |
GO:0031019 | mitochondrial mRNA editing complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0045293 | mRNA editing complex | 3 | 1 |
GO:0098798 | mitochondrial protein-containing complex | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
Related structures:
AlphaFold database: A4H556
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0010035 | response to inorganic substance | 3 | 1 |
GO:0010038 | response to metal ion | 4 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0016556 | mRNA modification | 6 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0042221 | response to chemical | 2 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0050896 | response to stimulus | 1 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000175 | 3'-5'-RNA exonuclease activity | 7 | 1 |
GO:0003824 | catalytic activity | 1 | 1 |
GO:0004518 | nuclease activity | 4 | 1 |
GO:0004519 | endonuclease activity | 5 | 1 |
GO:0004521 | RNA endonuclease activity | 5 | 1 |
GO:0004527 | exonuclease activity | 5 | 1 |
GO:0004532 | RNA exonuclease activity | 5 | 1 |
GO:0004540 | RNA nuclease activity | 4 | 1 |
GO:0005488 | binding | 1 | 3 |
GO:0008270 | zinc ion binding | 6 | 1 |
GO:0008408 | 3'-5' exonuclease activity | 6 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 1 |
GO:0016891 | RNA endonuclease activity, producing 5'-phosphomonoesters | 6 | 1 |
GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 1 |
GO:0016896 | RNA exonuclease activity, producing 5'-phosphomonoesters | 6 | 1 |
GO:0043167 | ion binding | 2 | 1 |
GO:0043169 | cation binding | 3 | 1 |
GO:0046872 | metal ion binding | 4 | 1 |
GO:0046914 | transition metal ion binding | 5 | 1 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 1 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003677 | DNA binding | 4 | 2 |
GO:0003697 | single-stranded DNA binding | 5 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 11 | 13 | PF00675 | 0.589 |
CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.617 |
CLV_NRD_NRD_1 | 32 | 34 | PF00675 | 0.504 |
CLV_PCSK_KEX2_1 | 11 | 13 | PF00082 | 0.571 |
CLV_PCSK_KEX2_1 | 198 | 200 | PF00082 | 0.608 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.595 |
CLV_PCSK_KEX2_1 | 32 | 34 | PF00082 | 0.504 |
CLV_PCSK_KEX2_1 | 95 | 97 | PF00082 | 0.435 |
CLV_PCSK_PC1ET2_1 | 198 | 200 | PF00082 | 0.608 |
CLV_PCSK_PC1ET2_1 | 95 | 97 | PF00082 | 0.435 |
CLV_PCSK_SKI1_1 | 198 | 202 | PF00082 | 0.526 |
CLV_PCSK_SKI1_1 | 24 | 28 | PF00082 | 0.588 |
CLV_PCSK_SKI1_1 | 33 | 37 | PF00082 | 0.550 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.567 |
DEG_SCF_FBW7_2 | 41 | 48 | PF00400 | 0.454 |
DEG_SPOP_SBC_1 | 120 | 124 | PF00917 | 0.687 |
DEG_SPOP_SBC_1 | 161 | 165 | PF00917 | 0.747 |
DOC_CKS1_1 | 42 | 47 | PF01111 | 0.663 |
DOC_MAPK_gen_1 | 95 | 103 | PF00069 | 0.672 |
DOC_MAPK_MEF2A_6 | 325 | 333 | PF00069 | 0.535 |
DOC_MAPK_MEF2A_6 | 412 | 421 | PF00069 | 0.382 |
DOC_PP2B_PxIxI_1 | 416 | 422 | PF00149 | 0.382 |
DOC_PP4_FxxP_1 | 146 | 149 | PF00568 | 0.659 |
DOC_PP4_FxxP_1 | 358 | 361 | PF00568 | 0.464 |
DOC_PP4_FxxP_1 | 380 | 383 | PF00568 | 0.513 |
DOC_SPAK_OSR1_1 | 393 | 397 | PF12202 | 0.408 |
DOC_USP7_MATH_1 | 162 | 166 | PF00917 | 0.716 |
DOC_USP7_MATH_1 | 178 | 182 | PF00917 | 0.578 |
DOC_USP7_MATH_1 | 189 | 193 | PF00917 | 0.538 |
DOC_USP7_MATH_1 | 250 | 254 | PF00917 | 0.700 |
DOC_USP7_UBL2_3 | 91 | 95 | PF12436 | 0.594 |
DOC_WW_Pin1_4 | 116 | 121 | PF00397 | 0.624 |
DOC_WW_Pin1_4 | 127 | 132 | PF00397 | 0.705 |
DOC_WW_Pin1_4 | 137 | 142 | PF00397 | 0.560 |
DOC_WW_Pin1_4 | 164 | 169 | PF00397 | 0.715 |
DOC_WW_Pin1_4 | 176 | 181 | PF00397 | 0.712 |
DOC_WW_Pin1_4 | 230 | 235 | PF00397 | 0.746 |
DOC_WW_Pin1_4 | 24 | 29 | PF00397 | 0.698 |
DOC_WW_Pin1_4 | 41 | 46 | PF00397 | 0.512 |
LIG_14-3-3_CanoR_1 | 12 | 20 | PF00244 | 0.647 |
LIG_CaM_IQ_9 | 203 | 219 | PF13499 | 0.447 |
LIG_Clathr_ClatBox_1 | 100 | 104 | PF01394 | 0.663 |
LIG_FHA_1 | 207 | 213 | PF00498 | 0.452 |
LIG_FHA_1 | 241 | 247 | PF00498 | 0.773 |
LIG_FHA_1 | 370 | 376 | PF00498 | 0.386 |
LIG_FHA_1 | 395 | 401 | PF00498 | 0.396 |
LIG_FHA_1 | 69 | 75 | PF00498 | 0.522 |
LIG_FHA_2 | 32 | 38 | PF00498 | 0.710 |
LIG_LIR_Apic_2 | 356 | 361 | PF02991 | 0.452 |
LIG_LIR_Gen_1 | 367 | 376 | PF02991 | 0.403 |
LIG_LIR_Nem_3 | 269 | 273 | PF02991 | 0.663 |
LIG_LIR_Nem_3 | 367 | 373 | PF02991 | 0.421 |
LIG_LIR_Nem_3 | 71 | 75 | PF02991 | 0.512 |
LIG_LYPXL_yS_3 | 416 | 419 | PF13949 | 0.385 |
LIG_PDZ_Class_2 | 426 | 431 | PF00595 | 0.411 |
LIG_Pex14_2 | 142 | 146 | PF04695 | 0.693 |
LIG_SH2_CRK | 414 | 418 | PF00017 | 0.405 |
LIG_SH2_STAT3 | 292 | 295 | PF00017 | 0.684 |
LIG_SH2_STAT3 | 343 | 346 | PF00017 | 0.329 |
LIG_SH2_STAT5 | 292 | 295 | PF00017 | 0.564 |
LIG_SH2_STAT5 | 343 | 346 | PF00017 | 0.484 |
LIG_SH2_STAT5 | 50 | 53 | PF00017 | 0.671 |
LIG_SH3_3 | 231 | 237 | PF00018 | 0.720 |
LIG_SH3_3 | 249 | 255 | PF00018 | 0.712 |
LIG_SH3_3 | 298 | 304 | PF00018 | 0.501 |
LIG_SH3_3 | 309 | 315 | PF00018 | 0.476 |
LIG_SH3_3 | 360 | 366 | PF00018 | 0.471 |
LIG_TRAF2_1 | 314 | 317 | PF00917 | 0.475 |
MOD_CDK_SPK_2 | 24 | 29 | PF00069 | 0.497 |
MOD_CDK_SPxK_1 | 41 | 47 | PF00069 | 0.456 |
MOD_CK1_1 | 116 | 122 | PF00069 | 0.640 |
MOD_CK1_1 | 132 | 138 | PF00069 | 0.720 |
MOD_CK1_1 | 164 | 170 | PF00069 | 0.734 |
MOD_CK1_1 | 233 | 239 | PF00069 | 0.633 |
MOD_CK2_1 | 154 | 160 | PF00069 | 0.637 |
MOD_CK2_1 | 178 | 184 | PF00069 | 0.716 |
MOD_Cter_Amidation | 30 | 33 | PF01082 | 0.498 |
MOD_GlcNHglycan | 134 | 137 | PF01048 | 0.644 |
MOD_GlcNHglycan | 187 | 190 | PF01048 | 0.711 |
MOD_GlcNHglycan | 191 | 194 | PF01048 | 0.682 |
MOD_GlcNHglycan | 287 | 290 | PF01048 | 0.494 |
MOD_GlcNHglycan | 424 | 427 | PF01048 | 0.495 |
MOD_GSK3_1 | 116 | 123 | PF00069 | 0.618 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.689 |
MOD_GSK3_1 | 160 | 167 | PF00069 | 0.653 |
MOD_GSK3_1 | 172 | 179 | PF00069 | 0.638 |
MOD_GSK3_1 | 185 | 192 | PF00069 | 0.590 |
MOD_GSK3_1 | 240 | 247 | PF00069 | 0.705 |
MOD_GSK3_1 | 31 | 38 | PF00069 | 0.657 |
MOD_GSK3_1 | 365 | 372 | PF00069 | 0.564 |
MOD_N-GLC_2 | 328 | 330 | PF02516 | 0.398 |
MOD_NEK2_1 | 14 | 19 | PF00069 | 0.504 |
MOD_NEK2_1 | 150 | 155 | PF00069 | 0.638 |
MOD_NEK2_1 | 201 | 206 | PF00069 | 0.447 |
MOD_NEK2_1 | 350 | 355 | PF00069 | 0.474 |
MOD_NEK2_1 | 394 | 399 | PF00069 | 0.451 |
MOD_NEK2_2 | 206 | 211 | PF00069 | 0.447 |
MOD_NEK2_2 | 266 | 271 | PF00069 | 0.666 |
MOD_NEK2_2 | 68 | 73 | PF00069 | 0.517 |
MOD_PIKK_1 | 405 | 411 | PF00454 | 0.556 |
MOD_PKA_2 | 31 | 37 | PF00069 | 0.710 |
MOD_Plk_4 | 113 | 119 | PF00069 | 0.514 |
MOD_Plk_4 | 14 | 20 | PF00069 | 0.469 |
MOD_Plk_4 | 424 | 430 | PF00069 | 0.312 |
MOD_ProDKin_1 | 116 | 122 | PF00069 | 0.626 |
MOD_ProDKin_1 | 127 | 133 | PF00069 | 0.700 |
MOD_ProDKin_1 | 137 | 143 | PF00069 | 0.555 |
MOD_ProDKin_1 | 164 | 170 | PF00069 | 0.719 |
MOD_ProDKin_1 | 176 | 182 | PF00069 | 0.711 |
MOD_ProDKin_1 | 230 | 236 | PF00069 | 0.747 |
MOD_ProDKin_1 | 24 | 30 | PF00069 | 0.694 |
MOD_ProDKin_1 | 41 | 47 | PF00069 | 0.513 |
MOD_SUMO_for_1 | 94 | 97 | PF00179 | 0.618 |
TRG_DiLeu_BaEn_2 | 196 | 202 | PF01217 | 0.662 |
TRG_DiLeu_BaLyEn_6 | 38 | 43 | PF01217 | 0.688 |
TRG_DiLeu_BaLyEn_6 | 70 | 75 | PF01217 | 0.396 |
TRG_ENDOCYTIC_2 | 416 | 419 | PF00928 | 0.385 |
TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.607 |
TRG_ER_diArg_1 | 11 | 13 | PF00400 | 0.577 |
TRG_Pf-PMV_PEXEL_1 | 33 | 37 | PF00026 | 0.688 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1P1 | Leptomonas seymouri | 53% | 92% |
A0A0S4IKI2 | Bodo saltans | 46% | 100% |
A0A1X0NPK8 | Trypanosomatidae | 47% | 100% |
A0A3S5H616 | Leishmania donovani | 72% | 87% |
A0A422N9Y4 | Trypanosoma rangeli | 49% | 100% |
A4HTD3 | Leishmania infantum | 72% | 96% |
C9ZUI1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 100% |
E9ALC6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 72% | 86% |
Q4QIH9 | Leishmania major | 73% | 100% |
V5DQ35 | Trypanosoma cruzi | 47% | 100% |